GlassScriptPhysician profile
Jeffrey D Moffett
NPI 1447257985
$2,168.08
in general payments reported to CMS, 2019-2025
7 companies · $20.04 in 2025
The $20.04 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.97 · 2020: $30.97 · 2021: $1,839 · 2022: $166 · 2023: $24.91 · 2024: $14.79 · 2025: $20.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $59.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $59.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,412.00 | 2021 | |
| Pylant Medical | $412.19 | 2021 | |
| Depuy Synthes Sales INC. | $177.35 | 2020-2022 | |
| Medical Device Business Services, INC. | $87.05 | 2019-2021 | |
| Glaxosmithkline, LLC. | $34.83 | 2024-2025 | Trelegy Ellipta |
| Polynovo North America LLC | $24.91 | 2023 | |
| Sanofi-Aventis U.S. LLC | $19.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Moffett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.